What is MedaCheck?
MedaCheck, LLC, offers Titan, a customizable and HIPAA-compliant health IT platform engineered for healthcare organizations and businesses. The platform features a cutting-edge API, secure data storage, and integrated medical adherence functionalities, all designed to elevate patient health management. Titan caters to a broad spectrum of clients, including clinical settings, medical device manufacturers, software developers, and research entities engaged in clinical trials. The company leverages its deep expertise in health technology to deliver impactful solutions to the Health IT community.
How much funding has MedaCheck raised?
MedaCheck has raised a total of $1.2M across 2 funding rounds:
Series A
$1.1M
Debt
$11K
Series A (2015): $1.2M with participation from Queen City Angels
Debt (2021): $11K led by PPP
Key Investors in MedaCheck
Queen City Angels
Queen City Angels is an investor network dedicated to supporting entrepreneurs and early-stage companies by facilitating access to funding, mentorship, and expert guidance. They invest in disruptive startups and actively support portfolio growth.
PPP
Public-Private Partnership
What's next for MedaCheck?
The recent infusion of moderate growth capital suggests MedaCheck is poised for scaling its operations and expanding its market reach. This strategic financing will likely fuel further development of the Titan platform, enhance its API capabilities, and bolster its secure data storage solutions. The company's focus on clinical trials and diverse healthcare applications indicates a trajectory towards solidifying its position as a key player in the Health IT ecosystem, potentially exploring new partnerships and client acquisitions to drive sustained expansion.
See full MedaCheck company page
